Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RARB | P10826 | 15/20 | 1.00 |
| ▸ | RARA | P10276 | 2/20 | 1.00 |
| ▸ | MEN1 | O00255 | 1/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 1.00 |
| ▸ | MAPT | P10636 | 1/20 | 1.00 |
| ▸ | MTOR | P42345 | 1/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 1/20 | 1.00 |
| ▸ | NPC1 | O15118 | 1/20 | 0.67 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.67 |
| ▸ | RAB9A | P51151 | 1/20 | 0.67 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.67 |
| ▸ | RELA | Q04206 | 1/20 | 0.67 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.67 |
| ▸ | RARG | P13631 | 1/20 | 0.64 |
| ▸ | THRA | P10827 | 1/20 | 0.61 |
| ▸ | THRB | P10828 | 1/20 | 0.61 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.60 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11113720 | 1.00 | RARB (1.00) | RARBRARAMEN1ALDH1A1MAPT | |
| SCHEMBL2402567 | 1.00 | RARB (1.00) | RARBRARAMEN1ALDH1A1MAPT | |
| SCHEMBL7542464 | 1.00 | RARB (1.00) | RARBRARAMEN1ALDH1A1MAPT | |
| SCHEMBL8533917 | 1.00 | RARB (1.00) | RARBRARAMEN1ALDH1A1MAPT | |
| SCHEMBL8531633 | 1.00 | RARB (1.00) | RARBRARAMEN1ALDH1A1MAPT | |
| SCHEMBL23484727 | 1.00 | RARB (1.00) | RARBRARAMEN1ALDH1A1MAPT | |
| SCHEMBL4174144 | 1.00 | RARB (1.00) | RARBRARAMEN1ALDH1A1MAPT | |
| SCHEMBL3088908 | 1.00 | RARB (1.00) | RARBRARAMEN1ALDH1A1MAPT | |
| SCHEMBL8536621 | 1.00 | RARB (1.00) | RARBRARAMEN1ALDH1A1MAPT | |
| Hydrochloric Acid SCHEMBL6024255 | 0.98 | RARB (0.97) | RARBRARAMEN1ALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 52 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114149616-B | Heat conducting filler, preparation method, resin composite material containing heat conducting filler and application of resin composite material | 全球能源互联网研究院有限公司 | 2023-11-28 | — | — | CN | claimed |
| CN-114149616-A | Heat-conducting filler, preparation method, resin composite material containing heat-conducting filler and application of resin composite material | 全球能源互联网研究院有限公司 | 2022-03-08 | — | — | CN | claimed |
| CN-114149616-B | Heat conducting filler, preparation method, resin composite material containing heat conducting filler and application of resin composite material | 全球能源互联网研究院有限公司 | 2023-11-28 | — | — | CN | disclosed |
| US-20220296579-A1 | COMPOSITIONS AND METHODS FOR PROVIDING CARDIOPROTECTIVE EFFECTS | CORNELL UNIVERSITY (US) | 2022-09-22 | — | — | US | disclosed |
| CN-114149616-A | Heat-conducting filler, preparation method, resin composite material containing heat-conducting filler and application of resin composite material | 全球能源互联网研究院有限公司 | 2022-03-08 | — | — | CN | disclosed |
| US-11191755-B2 | Compositions and methods for providing cardioprotective effects | CORNELL UNIVERSITY (US) | 2021-12-07 | — | — | US | disclosed |
| US-11160769-B2 | Methods of treating metabolic syndrome related conditions using retinoic acid receptor agonists | CORNELL UNIVERSITY (US) | 2021-11-02 | — | — | US | disclosed |
| US-10611786-B2 | Manganese (III) catalyzed C—H aminations | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2020-04-07 | — | — | US | disclosed |
| CN-106854194-B | Photosensitive material and optical device | 财团法人工业技术研究院 | 2019-12-06 | — | — | CN | disclosed |
| US-20190106448-A1 | MANGANESE (III) CATALYZED C--H AMINATIONS | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2019-04-11 | — | — | US | disclosed |
| US-9976085-B2 | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element | CHI MEI CORPORATION (TW) | 2018-05-22 | — | — | US | disclosed |
| WO-1998046563-A1 | METALLOPROTEINASE INHIBITORS | BRITISH BIOTECH PHARMACEUTICALS LIMITED (GB) | 1998-10-22 | — | — | WO | disclosed |
| EP-0341686-B1 | Novel halogen-containing ester compounds, and their intermediates, and method of producing the same as well as liquid crystal compositions containing the same and light switching elements | JAPAN ENERGY CORP (JP) | 1994-08-17 | — | — | EP | disclosed |
| US-5098602-A | Aromatic ester derivatives and fluorophenol ketones | NIPPON MINING CO., LTD. (JP) | 1992-03-24 | — | — | US | disclosed |
| EP-0341686-A2 | Novel halogen-containing ester compounds, and their intermediates, and method of producing the same as well as liquid crystal compositions containing the same and light switching elements | JAPAN ENERGY CORPORATION (JP) | 1989-11-15 | — | — | EP | disclosed |
| US-4708441-A | LIQUID CRYSTALS | HOFFMAN-LA ROCHE INC. (US) | 1987-11-24 | — | — | US | disclosed |
| US-4550981-A | Liquid crystalline esters and mixtures | HOFFMANN-LA ROCHE INC. (US) | 1985-11-05 | — | — | US | disclosed |
| US-4136053-A | BIPHENYL ESTERS AND LIQUID CRYSTALLINE MIXTURES COMPRISING THEM | MERCK PATENT GESELLSCHAFT MIT BESCHANKTER HAFTUNG (DE) | 1979-01-23 | — | — | US | disclosed |
| US-4073742-A | Cyano-substituted biphenyl compounds and liquid crystalline dielectrics containing the same | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DT) | 1978-02-14 | — | — | US | disclosed |
| US-4065489-A | Biphenyl esters and liquid crystalline mixtures comprising them | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DT) | 1977-12-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220296579-A1 | COMPOSITIONS AND METHODS FOR PROVIDING CARDIOPROTECTIVE EFFECTS | RARB, RARG, RARA | RARB 1/4885RARA 3/4885MEN1 4881/4885 |
| US-11191755-B2 | Compositions and methods for providing cardioprotective effects | RARB, RARG, RARA | RARB 1/4885RARA 3/4885MEN1 4881/4885 |
| US-11160769-B2 | Methods of treating metabolic syndrome related conditions using retinoic acid receptor agonists | RARA, RARG, RXRA | RARB 5/4885RARA 1/4885MEN1 3112/4885 |
| US-10611786-B2 | Manganese (III) catalyzed C—H aminations | HLCS, NCL, NUDC | RARB 1228/4885RARA 1977/4885MEN1 180/4885 |
| US-20190106448-A1 | MANGANESE (III) CATALYZED C--H AMINATIONS | HLCS, NCL, NUDC | RARB 886/4885RARA 1482/4885MEN1 268/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.